Navigation Links
CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
Date:9/15/2008

ST LOUIS, Sept. 15 /PRNewswire/ -- CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced the commercial launch of its new 4D treatment planning solution, Focal4D(TM).

Focal4D, part of the Focal product line that also includes FocalSim and FocalPro, provides a comprehensive suite of capabilities that support the visualization and utilization of 4D image sets to create structures and review treatment options. With support for respiratory-correlated CT images, the robust toolset includes multiple viewing options such as cine and variable window formats and automated processes for creation of Internal Target Volumes.

"Focal4D provides a comprehensive suite of capabilities that support the visualization and utilization of 4D image sets to create structures and review treatment options. Its visualization and contouring tools help clinicians improve the planning process by taking into account how a patient's anatomy moves over time," says Jennifer Markham, Focal4D Product Manager. "With the ever-changing technology in Radiation Oncology, the opportunity to provide better patient care exists. By incorporating functionality to support this improved technology, Focal4D provides real solutions that address real clinical needs."

Focal4D joins the rest of the Focal product line as a key component in the comprehensive suite of radiation therapy planning tools offered by CMS. As CMS continues to develop cutting edge software to improve patient care, Focal4D is the next step in treatment planning for tumor motion.

About CMS

CMS, Inc., an Elekta Company, is a worldwide market leader in radiation treatment planning and workflow management, combining innovative software applications and advanced technology tools to deliver comprehensive treatment planning and workflow management solutions that integrate seamlessly in any clinical environment. With a commitment to product excellence and a reputation for world-class service and support, CMS makes all members of the treatment team more effective in providing patient care.

CMS is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.

With more than 2,500 employees globally, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at http://www.cmsrtp.com and http://www.elekta.com.


'/>"/>
SOURCE CMS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
2. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
3. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
4. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
5. Raj Khankari Named Bioenergy, Inc., CEO
6. Bioheart, Inc., Announces Management Change
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Bioheart, Inc., Added to Russell Microcap Index
9. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
10. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
11. Solei Systems, Inc., Announces That the Company Is Now Publicly Traded
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, with its ... place for a head lice treatment salon to set up ... Tuscan restaurant and a French bistro on E Madison Ave, ... aren,t just any old lice clinic, we pride ourselves on ... and release some of the stigma associated with lice. Everyone ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one members ... named Fellows of the Society this year, the Fellows Committee has announced. The ... of optics, photonics, and imaging as well as their service to the Society ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):